首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody

Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody

产品编号

YR1202

别名

科研级 Rovelizumab ( 罗维珠单抗 ), Anti-ITGAL & CD11a & CD18 Recombinant Antibody, Research Grade Rovelizumab

规格
  • 1mg
  • 5mg
产品介绍
Catalog NumberYR1202
Alias科研级 Rovelizumab ( 罗维珠单抗 ), Anti-ITGAL & CD11a & CD18 Recombinant Antibody, Research Grade Rovelizumab
Size1mg, 5mg
Molecular NameRovelizumab
CAS Number339086-79-2
TargetITGAL & CD11a & CD18[Homo sapiens]
Antibody IsotypeIgG4
ClonityMonoclonal
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundRovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. Rovelizumab was developed by Icos to treat patients suffering from haemorrhagic shock. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock.
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价